Who makes FDA approved anti arrhythmic drug?

FDA approved anti arrhythmic drug is developed by The Cleveland Clinic.

What development phase is FDA approved anti arrhythmic drug in?

FDA approved anti arrhythmic drug is FDA-approved (marketed).

Last reviewed 2026-05-14 · How we verify

FDA approved anti arrhythmic drug

The Cleveland Clinic · FDA-approved active Small molecule Quality 2/100

At a glance

Generic name	FDA approved anti arrhythmic drug
Sponsor	The Cleveland Clinic
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Liraglutide Effect in Atrial Fibrillation (PHASE4)
Catheter Ablation vs. Medical Therapy in Congested Hearts With AF (PHASE4)
Treatment Of Atrial Fibrillation In Preserved Cardiac Function Heart Failure (PHASE4)
Pilot Study of Catheter Ablation for Ventricular Tachycardia in Patients With an Implantable Cardioverter Defibrillator (NA)
AV Node Ablation and Pacemaker Therapy Compared to Drug Therapy for Atrial Fibrillation - Pilot Study (PHASE3)
A Study of the Effectiveness of Anti-Arrhythmic Medications After Atrial Fibrillation Ablation (NA)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

FDA approved anti arrhythmic drug CI brief — competitive landscape report
FDA approved anti arrhythmic drug updates RSS · CI watch RSS
The Cleveland Clinic portfolio CI